Health Care • Medical/Nursing Services
$124.34 ▲ +2.16
(+1.77%)
MKT CAP: $2.32B • VOL: 331.6K
52W L $88 52W H $127
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$104
MEDIAN
$139
MEAN
$142
HIGH
$169
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ADUS TAPE
ADUS // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $150.45 | $142.99 | 2025-02-14 | $113.15 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $156.67 | $146.72 | 2025-02-06 | $116.88 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $141.75 | $136.77 | 2025-01-29 | $119.37 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $126.83 | — | 2025-01-17 | $121.85 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $109.42 | $118.12 | 2025-01-09 | $110.66 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $147.96 | $129.31 | 2024-12-18 | $108.18 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $120.61 | $125.58 | 2024-12-04 | $115.64 | -4.3% | 48% | C |